NASDAQ NMS - GLOBAL MARKET · CNTB
+2.12% · +$0.0500 · Vol Not reported
Pre-market · updated 04:02:51 ET
Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Ltd

Biotechnology
$2.41
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
CNTB
Connect Biopharma Holdings Ltd
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CNTB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CNTB catalysts
About Connect Biopharma Holdings Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
2025
Employees
64
Country
US

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.36
Last session
Day high
$2.36
Last session
Day low
$2.36
Last session
Previous close
$2.36
52W high
$3.69
-34.69% from high
52W low
$1.32
46% of range
Market cap
$148.6M
EPS
$-1.1100
Beta
1.21
Shares out
63M
Avg volume
394.1K
VWAP
$2.36
Last session
Price history computed in-house
1W
-3.21%
1M
+12.62%
3M
+0.42%
1Y
+31.69%
YTD
-14.54%
SMA 50 $2.24 · above
SMA 200 $2.45 · below
52W position 46%

CNTB overview

Veridion Score
59
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CNTB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CNTB Form 4 filings
Public disclosures

Congress activity in CNTB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CNTB in the cached public ledger.

Federal contracts

CNTB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CNTB in this window.
Lobbying spend

CNTB lobbying filings, year to date.

Registered lobbying filings matched to Connect Biopharma Holdings Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CNTB in this window.
Loading news for CNTB
Analyst ratings
Sovereign unlock shows live analyst consensus for CNTB.
Options
Sovereign unlock shows live options positioning for CNTB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.